Pemphigus: analysis of 1209 cases
- PMID: 15941433
- DOI: 10.1111/j.1365-4632.2004.02501.x
Pemphigus: analysis of 1209 cases
Abstract
Background: Pemphigus is a rare and chronic life-threatening disease. The clinical picture varies in reports from different regions of the world.
Objective: To define the clinical forms of pemphigus in a large cohort of patients.
Methods: Prospective analysis of 1209 patients diagnosed and followed at the Pemphigus Research Unit, Tehran University for Medical Sciences, from 1984 to 2003.
Results: The mean age at onset was 42 years with a female to male ratio of 1.5/1. The most frequent form was pemphigus vulgaris. In pemphigus vulgaris, patients' mucous membrane involvement alone was observed in 18%, skin involvement alone in 12%, and both in 70%. Pemphigus foliaceus was observed in 7% of the patients. Most complications were iatrogenic.
Conclusion: In Iran, pemphigus vulgaris is the most frequent form of pemphigus. Females are more prone to the disease. The incidence of pemphigus in Tehran is approximately 1.6 per 100,000/year, and in Iran 1.0 per 100,000/year. The age of onset was lower than classically reported. Death occurred in 6.2% of the patients. In pemphigus vulgaris, the mucosal and skin form together had a worse prognosis than the other clinical forms.
Similar articles
-
Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000).Int J Dermatol. 2006 Feb;45(2):103-5. doi: 10.1111/j.1365-4632.2004.02374.x. Int J Dermatol. 2006. PMID: 16445496
-
Pemphigus vulgaris in Iran: a clinical study of 140 cases.Int J Dermatol. 2007 Nov;46(11):1166-70. doi: 10.1111/j.1365-4632.2007.03334.x. Int J Dermatol. 2007. PMID: 17988336
-
Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.Br J Dermatol. 2009 Oct;161(4):861-8. doi: 10.1111/j.1365-2133.2009.09300.x. Epub 2009 May 8. Br J Dermatol. 2009. PMID: 19566661
-
Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris.Pediatr Dermatol. 2011 Sep-Oct;28(5):485-93. doi: 10.1111/j.1525-1470.2011.01514.x. Epub 2011 Aug 23. Pediatr Dermatol. 2011. PMID: 21883426 Review.
-
Ear, nose and throat manifestations in pemphigus vulgaris.Br J Dermatol. 2007 Apr;156(4):733-7. doi: 10.1111/j.1365-2133.2007.07783.x. Br J Dermatol. 2007. PMID: 17493073 Review.
Cited by
-
Management of Pemphigus Vulgaris.Adv Ther. 2016 Jun;33(6):910-58. doi: 10.1007/s12325-016-0343-4. Epub 2016 Jun 10. Adv Ther. 2016. PMID: 27287854 Free PMC article. Review.
-
A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study.Dermatol Ther (Heidelb). 2020 Feb;10(1):179-189. doi: 10.1007/s13555-019-00346-x. Epub 2019 Dec 21. Dermatol Ther (Heidelb). 2020. PMID: 31865535 Free PMC article.
-
Epidemiology of Pemphigus.JID Innov. 2021 Feb 20;1(1):100004. doi: 10.1016/j.xjidi.2021.100004. eCollection 2021 Mar. JID Innov. 2021. PMID: 34909708 Free PMC article. Review.
-
Pemphigus foliaceus as a differential diagnosis in vesicobullous lesions.Einstein (Sao Paulo). 2017 Apr-Jun;15(2):220-222. doi: 10.1590/S1679-45082017RC3828. Einstein (Sao Paulo). 2017. PMID: 28767922 Free PMC article.
-
A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up.Turk J Med Sci. 2021 Feb 26;51(1):124-133. doi: 10.3906/sag-2006-231. Turk J Med Sci. 2021. PMID: 32892539 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical